Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Crohn'S & Colitis 360|April 24, 2026
Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trialWalter Reinisch, Laurent Peyrin-Biroulet, Geert D'Haens, et al.
The New England Journal of Medicine|March 31, 2021
Trial of Upadacitinib and Adalimumab for Psoriatic ArthritisIain B McInnes, Jaclyn K Anderson, Marina Magrey, et al.
Annals of the Rheumatic Diseases|December 4, 2020
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2Philip J Mease, Apinya Lertratanakul, Jaclyn K Anderson, et al.
The Journal of Allergy and Clinical Immunology|December 2, 2019
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trialEmma Guttman-Yassky, Diamant Thaçi, Aileen L Pangan, et al.
Lancet (London, England)|July 3, 2018
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind studyRobert Landewé, Joachim Sieper, Philip Mease, et al.
The Lancet. Gastroenterology & Hepatology|June 2, 2025
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trialBrian G Feagan, Bruce E Sands, Corey A Siegel, et al.
Pageof 2